Skip to main content
Top
Published in: Clinical Research in Cardiology 9/2021

01-09-2021 | Stroke | Original Paper

Outcomes in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis

Authors: Laurent Fauchier, Arnaud Bisson, Alexandre Bodin, Julien Herbert, Denis Angoulvant, Nicolas Danchin, Yves Cottin

Published in: Clinical Research in Cardiology | Issue 9/2021

Login to get access

Abstract

Background

In patients with acute myocardial infarction (AMI), history of atrial fibrillation (AF) and new onset AF during the early phase may be associated with a worse prognosis. Whether both conditions are associated with similar outcomes is a matter of debate.

Methods

We collected information for all patients with AMI seen in French hospitals between 2010 and 2019. Among 797,212 patients seen with STEMI or NSTEMI, 75,701 (9.5%) had history of AF, and 34,768 (4.4%) had new AF diagnosed between day 1 and day 30 after AMI.

Results

Patients with new AF were older and had more comorbidities than those with no AF but were younger and had less comorbidities than those with history of AF. During follow-up [mean (SD) 1.8 (2.4) years, median (interquartile range) 0.7 (0.1–3.1) years], 163,845 deaths and 30,672 ischemic strokes were recorded. Using Cox multivariable analysis, compared to patients with no AF, history of AF was associated with a higher risk of death during follow-up (adjusted hazard ratio HR 1.17, 95% CI 1.16–1.19) and this was also the case for patients with new AF (adjusted HR 2.11, 2.07–2.15). Both history of AF and new AF were associated with a higher risk of ischemic stroke compared to patients with no AF: adjusted HR 1.19 (1.15–1.23) for history of AF, adjusted HR 1.78 (1.68–1.88) for new AF. New AF was associated with a higher risk of death and of ischemic stroke than history of AF: adjusted HR 1.74 (1.70–1.79) and 1.32 (1.23–1.42), respectively.

Conclusions

In a large and systematic nationwide analysis, AF first recorded in the first 30 days after AMI was independently associated with higher risks of death and ischemic stroke than those in patients with no AF or previously known AF.

Graphic abstract

Literature
6.
go back to reference Djennaoui M, Ficheur G, Beuscart R, Chazard E (2015) Improvement of the quality of medical databases: data-mining-based prediction of diagnostic codes from previous patient codes. Stud Health Technol Inform 210:419–423PubMed Djennaoui M, Ficheur G, Beuscart R, Chazard E (2015) Improvement of the quality of medical databases: data-mining-based prediction of diagnostic codes from previous patient codes. Stud Health Technol Inform 210:419–423PubMed
7.
go back to reference Bezin J, Pariente A, Lassalle R, Dureau-Pournin C, Abouelfath A, Robinson P, Moore N, Droz-Perroteau C, Fourrier-Reglat A (2014) Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France. Eur J Clin Pharmacol 70(4):429–436. https://doi.org/10.1007/s00228-013-1614-5CrossRefPubMed Bezin J, Pariente A, Lassalle R, Dureau-Pournin C, Abouelfath A, Robinson P, Moore N, Droz-Perroteau C, Fourrier-Reglat A (2014) Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France. Eur J Clin Pharmacol 70(4):429–436. https://​doi.​org/​10.​1007/​s00228-013-1614-5CrossRefPubMed
8.
go back to reference Massoullié G, Wintzer-Wehekind J, Chenaf C, Mulliez A, Pereira B, Authier N, Eschalier A, Clerfond G, Souteyrand G, Tabassome S, Danchin N, Citron B, Lusson JR, Puymirat É, Motreff P, Eschalier R (2016) Prognosis and management of myocardial infarction: comparisons between the French FAST-MI 2010 registry and the French public health database. Arch Cardiovasc Dis 109(5):303–310. https://doi.org/10.1016/j.acvd.2016.01.012CrossRefPubMed Massoullié G, Wintzer-Wehekind J, Chenaf C, Mulliez A, Pereira B, Authier N, Eschalier A, Clerfond G, Souteyrand G, Tabassome S, Danchin N, Citron B, Lusson JR, Puymirat É, Motreff P, Eschalier R (2016) Prognosis and management of myocardial infarction: comparisons between the French FAST-MI 2010 registry and the French public health database. Arch Cardiovasc Dis 109(5):303–310. https://​doi.​org/​10.​1016/​j.​acvd.​2016.​01.​012CrossRefPubMed
11.
go back to reference Laurent G, Dentan G, Moreau D, Zeller M, Laurent Y, Vincent-Martin M, Lhuillier I, Makki H, Wolf JE, Cottin Y (2005) Atrial fibrillation during myocardial infarction with and without ST segment elevation. Arch Mal Coeur Vaiss 98(6):608–614PubMed Laurent G, Dentan G, Moreau D, Zeller M, Laurent Y, Vincent-Martin M, Lhuillier I, Makki H, Wolf JE, Cottin Y (2005) Atrial fibrillation during myocardial infarction with and without ST segment elevation. Arch Mal Coeur Vaiss 98(6):608–614PubMed
16.
go back to reference Lip GYH, Collet JP, Haude M, Byrne R, Chung EH, Fauchier L, Halvorsen S, Lau D, Lopez-Cabanillas N, Lettino M, Marin F, Obel I, Rubboli A, Storey RF, Valgimigli M, Huber K (2019) 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace Eur Pacing Arrhythmias Cardiac Electrophysiol J Work Groups Cardiac Pacing Arrhythmias Cardiac Cell Electrophysiol Eur Soc Cardiol 21(2):192–193. https://doi.org/10.1093/europace/euy174CrossRef Lip GYH, Collet JP, Haude M, Byrne R, Chung EH, Fauchier L, Halvorsen S, Lau D, Lopez-Cabanillas N, Lettino M, Marin F, Obel I, Rubboli A, Storey RF, Valgimigli M, Huber K (2019) 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace Eur Pacing Arrhythmias Cardiac Electrophysiol J Work Groups Cardiac Pacing Arrhythmias Cardiac Cell Electrophysiol Eur Soc Cardiol 21(2):192–193. https://​doi.​org/​10.​1093/​europace/​euy174CrossRef
Metadata
Title
Outcomes in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis
Authors
Laurent Fauchier
Arnaud Bisson
Alexandre Bodin
Julien Herbert
Denis Angoulvant
Nicolas Danchin
Yves Cottin
Publication date
01-09-2021
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 9/2021
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-021-01805-2

Other articles of this Issue 9/2021

Clinical Research in Cardiology 9/2021 Go to the issue